Recent Quotes (30 days)

You have no recent quotes
chg | %

Medicago Inc.  

(Public, CVE:MDG)   Watch this stock  
Find more results for TSE:MDG
Apr 9 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.17 - 0.86
Open     -
Vol / Avg. 0.00/218,000.00
Mkt cap 48.06M
P/E     -
Div/yield     -
EPS -0.13
Shares     -
Beta 1.48
Inst. own     -

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin -988.37% -589.40%
Operating margin -988.37% -589.40%
EBITD margin - -482.24%
Return on average assets -69.41% -50.34%
Return on average equity - -146.17%
Employees 204 -
CDP Score - -


Bureau 600, 1020, route de l'Eglise
+1-418-6589393 (Phone)
+1-418-6586699 (Fax)

Website links


Medicago Inc (Medicago) is a clinical-stage biotechnology company. The Company is focused on the development of vaccines using its Virus-Like Particules (VLPs) and manufacturing technologies. Medicago�s VLP manufacturing technology is based on a transient expression system, which produces recombinant vaccine antigens in non-transgenic plants. Medicago operates a 24,000-square-foot production facility located in the Technology Park in Quebec City, Canada. This facility includes a Biosafety level 2 greenhouse, an extraction and purification unit, and is cGMP compliant. The Company�s products include Pandemic flu vaccine and Seasonal flu vaccine. Medicago U.S.A is a wholly owned subsidiary of Medicago.